ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00024661
Recruitment Status : Completed
First Posted : September 25, 2001
Last Update Posted : April 13, 2011
Sponsor:
Collaborator:
Georgetown University
Information provided by:
INSYS Therapeutics Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : October 2004